PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

Research output: Contribution to conferenceAbstract

  • External authors:
  • C Chan
  • A Bossons
  • K Franks
  • F McDonald
  • M Forster
  • r Mendes
  • S Quezada
  • Simon Dovedi
  • c Ralph
  • S Popat
  • K Harrington
  • A Melcher
  • A Popple

Bibliographical metadata

Original languageEnglish
Publication statusPublished - Jan 2017